Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients
CompletedOBSERVATIONAL
Enrollment
180
Participants
Timeline
Start Date
January 31, 2014
Primary Completion Date
January 31, 2016
Study Completion Date
January 31, 2016
Conditions
Colon Cancer Adenocarcinoma
Trial Locations (1)
100
National Taiwan University Hospital, Taipei
All Listed Sponsors
lead
National Taiwan University Hospital
OTHER
NCT02022995 - Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients | Biotech Hunter | Biotech Hunter